Very early researchEnded earlyNCT04116164What this trial is testingSafety and Targeting of Anti-hk2 Antibody in mCRPCWho this might be right forCastration-Resistant Prostatic CancerMetastatic Disease SpectronRX 27
Not applicableStudy completedNCT02398526What this trial is testingPain Evaluation in Radium-223 Treated Castration Resistant Prostate Cancer Patients With Bone MetastasesWho this might be right forCastration-Resistant Prostatic Cancer Bayer 363
Testing effectiveness (Phase 2)Study completedNCT00459186What this trial is testingThe Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate CancerWho this might be right forMetastatic, Androgen Independent Prostate CancerProstate Cancer Dana-Farber Cancer Institute 19
Testing effectiveness (Phase 2)Study completedNCT00878436What this trial is testingSafety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After CastrationWho this might be right forProstate CancerProstatic Neoplasms NYU Langone Health 52
Testing effectiveness (Phase 2)Study completedNCT00081172What this trial is testingRadiolabeled Monoclonal Antibody in Treating Patients With Progressive Metastatic Androgen-Independent Adenocarcinoma (Cancer) of the ProstateWho this might be right forProstate Cancer Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Ended earlyNCT00096304What this trial is testingEpirubicin and Docetaxel in Treating Patients With Metastatic Prostate CancerWho this might be right forProstate Cancer Medical University of South Carolina 36
Testing effectiveness (Phase 2)Study completedNCT00683475What this trial is testingIMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate CancerWho this might be right forProstate Cancer Eli Lilly and Company 138
Early research (Phase 1)Study completedNCT00113984What this trial is testingVaccine and Antibody Treatment of Prostate CancerWho this might be right forProstatic Neoplasms National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00134355What this trial is testingStudy of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate CancerWho this might be right forProstate Cancer University of Michigan Rogel Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT00064610What this trial is testingPhase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate CancerWho this might be right forProstatic Neoplasms Millennium Pharmaceuticals, Inc. 102
Testing effectiveness (Phase 2)Study completedNCT00182741What this trial is testingCalcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate CancerWho this might be right forProstate Cancer OHSU Knight Cancer Institute 19
Early research (Phase 1)Active Not RecruitingNCT04597411What this trial is testingStudy of 225Ac-PSMA-617 in Men With PSMA-positive Prostate CancerWho this might be right forProstatic Neoplasms, Castration-Resistant Endocyte 101
Testing effectiveness (Phase 2)Study completedNCT01540071What this trial is testingTrial of NRX 194204 in Castration- and Taxane-Resistant Prostate CancerWho this might be right forCastration Resistant Prostate Cancer Io Therapeutics 38
Testing effectiveness (Phase 2)Study completedNCT00480090What this trial is testingA Phase II Study of Ara-C (Cytarabine) in Men With Androgen Independent Prostate CancerWho this might be right forProstate Cancer University Health Network, Toronto 10
Early research (Phase 1)Looking for participantsNCT05519449What this trial is testingStudy of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)Who this might be right forProstate CancerMetastatic Castration-resistant Prostate CancerCastration Resistant Prostatic Cancer Janux Therapeutics 272
Testing effectiveness (Phase 2)UnknownNCT02049190What this trial is testingPhase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate CancerWho this might be right forProstate CancerMetastatic Prostate CancerAndrogen-independent Prostate Cancer+1 more Arno Therapeutics 75
Not applicableUnknownNCT00133900What this trial is testingCirculating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving ChemotherapyWho this might be right forHormone Refractory Prostate CancerProstate Cancer Immunicon 276
Testing effectiveness (Phase 2)Study completedNCT00350051What this trial is testingZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate CancerWho this might be right forProstate Cancer Bayer 53
Testing effectiveness (Phase 2)Study completedNCT00090545What this trial is testingA Phase II Study of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate CancerWho this might be right forProstate Cancer National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Study completedNCT00084825What this trial is testingDocetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008Who this might be right forMetastatic CancerProstate Cancer M.D. Anderson Cancer Center 23